Increased Incidence of Tumor Takes to B16 Melanoma in C57BL/6J Mice Injected with B16 Products
- 1 September 1980
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 75 (3) , 275-278
- https://doi.org/10.1111/1523-1747.ep12523542
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Resistance of neoplasms to immunological destruction: role of a macrophage chemotaxis inhibitor.The Journal of Experimental Medicine, 1978
- Host Control of Tumor GrowthScience, 1977
- Inhibition of mitogen-induced lymphocyte blastogenesis by serum from tumor-bearing animals: Changes with tumor growthPublished by Elsevier ,1976
- An Inhibitor of Macrophage Chemotaxis Produced by NeoplasmsScience, 1976
- The effects of plasma from guinea pigs with tumor on PHA stimulated lymphocyte culturesCellular Immunology, 1976
- Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.The Journal of Experimental Medicine, 1976
- Immunosuppression by micromolecular fibrinogen degradation products in cancerNature, 1976
- Factor(s) from Ehrlich Ascites Cells Responsible for Delayed Rejection of Skin Allografts in Mice and Its Assay on Lymphocytes in VitroExperimental Biology and Medicine, 1975
- Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with CancerNew England Journal of Medicine, 1974
- The Immune Recognition of Ta3 Tumors, Its Facilitation by Endotoxin, and Abrogation by Abcites FluidThe Journal of Immunology, 1972